
Haloperidol is a potent butyrophenone-class antipsychotic used in research to study dopamine D2 receptor antagonism and the management of acute psychosis.
In the competitive landscape of central nervous system (CNS) drug development, the precision of dopaminergic modulation defines the therapeutic efficacy. Haloperidol is selected for its exceptional affinity for the dopamine D2 receptors in the mesolimbic and nigrostriatal pathways. In addition, whether functioning as a critical active ingredient in acute agitation treatments or a robust reagent in Tourette syndrome research, it delivers reliable behavioral control across a wide range of laboratory conditions.
Zyntex supplies Haloperidol in a high-purity crystalline form, optimized for formulation into solid oral dosages and long-acting decanoate injectables. Moreover, our stringent quality control measures ensure a precise impurity profile and consistent particle size distribution, meeting the strict demands of global pharmaceutical standards for high-potency neuroleptics.
From specialized neurobiological research into schizophrenia pathways to large-scale production of anti-emetic agents, this versatile butyrophenone derivative is a staple for modern psychiatry. Consequently, its well-characterized chemical profile ensures predictable results in receptor binding assays, providing a dependable foundation for pharmaceutical innovation and neurological health development.
This professional-grade antipsychotic agent is widely utilized in the following sectors:
Primary tool for studying the pathophysiology of schizophrenia and the hyperdopaminergic hypothesis.
Key API for developing rapid-release oral tablets and long-acting intramuscular depot injections.
Used in research models focusing on motor tic suppression and the management of Huntington’s chorea symptoms.
Essential for investigating extrapyramidal side effects (EPS) and developing safer neuroleptic alternatives.
| Parameter | Specification Standard |
|---|---|
| Product Name | Haloperidol |
| Molecular Formula | C21H23ClFNO2 |
| Purity | Pharmaceutical Grade (Min. 99%) |
| Appearance | White to Faintly Yellowish Powder |
| CAS Number | 58-39-9 |
🔬 Scientific Data: For detailed handling, solubility, and safety data, consult: PubChem Entry: Haloperidol (External Link)